seriously... it's better to report rehashed news like this.
The company doesn't have major upcoming catalysts. It is expected to initiate phase II clinical trials of Z944 in the first quarter of 2014 and the data is estimated to be available in the second half. The success of the trials may prove to be the saving grace of the company. -SA
this is going to pop when PR comes out about starting the trials... few weeks?